Vertical Integration: A New Approach to Tackling Contrast Shortages in CT Imaging

Vertical Integration: A New Approach to Tackling Contrast Shortages in CT Imaging

The worldwide shortage of imaging contrast agents last year left medical providers struggling to provide proper diagnostic care for their patients. In response, North American pharmaceutical provider Voyageur Pharmaceuticals has implemented a new approach to tackle the shortage head-on. By using barium and iodine sources in Canada and the United States, the company has created…

Read More

Artificial Intelligence Can Aid Early Detection of Malignant Liver Tumors

Artificial Intelligence Explored to Aid Early Detection of Malignant Liver Tumors

Early detection of malignant liver tumors is crucial for improving a patient’s prognosis. The most common malignant liver tumor is hepatocellular carcinoma, which is often diagnosed too late because of the difficulty in distinguishing between it and other liver conditions. It’s often said that “time is liver” – delay in identifying and treating hepatocellular carcinoma…

Read More

Lung Abnormalities Continue Even 2 Years After Severe COVID

Lung Abnormalities Continue Even 2 Years After Severe COVID

Two recent studies confirm lung scarring and other abnormalities occur in many COVID patients — even two years later. The studies were conducted at the Margaret Turner Warwick Center for Fibrosing Lung Disease with Iain Stewart, PhD. as corresponding author and at Tongji Medical College of Huazhong University and led by co-senior authors Qing Ye,…

Read More

Over 500 Healthcare AI Algorithms Now Approved by FDA

Over 500 Healthcare AI Algorithms Now Approved by FDA

The FDA recently announced that more than 520 FDA-approved artificial intelligence (AI) medical algorithms are now available in the United States. AI algorithms in medicine are not new — the FDA approved the first AI algorithm in 1995. Growth was slow over the next 18 years. AI usage has dramatically risen in the last decade,…

Read More